However, modifiable risk factors like diet and exercise can significantly reduce weight-related complications
Semaglutide, tirzepatide, and retatrutide can all support healthier habits by helping patients manage appetite, cravings, and blood sugar
Combination Therapy Use of Semaglutide in Patients with Type 2 Diabetes Mellitus Combination with Metformin and/or Thiazolidinediones In a 56-week, double-blind trial (NCT01930188), 1231 patients with type 2 diabetes mellitus were randomized to semaglutide 0.5 mg once weekly, semaglutide 1 mg once weekly, or sitagliptin 100 mg once daily, all in combination with metformin (94%) and/or thiazolidinediones (6%)
A trend of decrease in total phospholipid level was noticed in Hitrechol TID (Group 5) in comparison to vehicle treated lithogenic diet group (Group 2) and Hitrechol (QD) treated Lithogenic diet group (Group 4), however, there was no statistically significant difference